EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Clinical profile and risk factors of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: A case-control study

Kaustav Bhowmick iD, Rashmi Roongta iD, Sumantro Mondal, Dipendra Nath Ghosh, Soumya Dey iD, Gautam Raj Panjabi, Angan Karmakar iD, Mavidi Sunil Kumar, Sonali Dey iD, Sudipta Ghorai, Partha Ghorai, Hiramanik Sit und 5 weitere

Lupus · 2025

DOI: 10.1177/09612033251366401 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Lupus, 2025. Verfasst von Kaustav Bhowmick und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, North Bengal Medical College, Darjeeling, India. Hauptthemen laut MEDLINE: Posterior Leukoencephalopathy Syndrome, Lupus Erythematosus, Systemic. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the clinical profile and risk factors of Posterior Reversible Encephalopathy Syndrome (PRES) in patients with Systemic Lupus Erythematosus (SLE).

Methods

In this retrospective study, the SLE patients admitted with PRES in the Department of Clinical Immunology and Rheumatology, IPGME&R, Kolkata, India from January 1, 2017 to January 31, 2024, were identified. Fifty-three control participants with neuropsychiatric symptoms as per the 1999 American College of Rheumatology case definition criteria were selected from the departmental SLE cohort.

Results

26 episodes of PRES were identified in 25 patients. Seizures (88.46%) and headaches (53.85%) were the commonest presenting manifestations with the occipital (96.15%) and parietal lobes (84.62%) being the commonly involved sites. Nephritis (96.15% vs 60.38%, p = 0.001), hypertension at PRES onset (76.92% vs 18.87%, p = 0.000), Direct Coomb’s test (DCT) positivity (50.00% vs 20.75%, p = 0.008), high extra-neurological disease activity (SELENA-SLEDAI – N : 20.62±8.77 vs 14.15 ± 5.51, p = 0.002), lupus enteritis (15.38% vs 1.89%, p = 0.038), and neutrophilia (73.08% vs 20.75%, p = 0.000) were identified as risk factors for PRES on univariate analysis. Multivariate analysis found hypertension [ p = 0.014], DCT positivity ( p = 0.013), neutrophilia ( p = 0.025), and lupus enteritis (0.038) as independent risk factors. The presence of U1RNP/Sm and prior thrombotic events were found to be protective against PRES on univariate analysis.

Conclusion

PRES in SLE in our study was associated with high extra-neurological disease activity. Hypertension, DCT positivity, neutrophilia, and lupus enteritis were identified as important risk factors for the condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Posterior Leukoencephalopathy SyndromeLupus Erythematosus, SystemicHumansFemaleMaleRisk FactorsAdultRetrospective StudiesCase-Control StudiesMiddle AgedIndiaYoung AdultSeizuresHypertension

Stichwörter der Autor:innen

PRESPosterior reversible encephalopathy syndromeneuropsychiatric lupussubacute lupus erythematosus

Autor:innen und Institutionen

  • Department of General Medicine, North Bengal Medical College, Darjeeling, India.
  • Department of Clinical Immunology and Rheumatology, Institute of Postgraduate Medical Education and Research, Kolkata, India.
  • Department of Clinical Immunology and Rheumatology, Ruby General Hospital, Kolkata, India.
  • Department of Clinical Immunology and Rheumatology, Medanta Superspeciality Hospital, Indore, India.
  • Department of General Medicine, Nilratan Sircar Medical College, Kolkata, India.
  • Department of Clinical Immunology and Rheumatology, Sunil Rheumatology and Immunology Center, Visakhapatnam, India.

ORCID-Profile: Kaustav Bhowmick, Rashmi Roongta, Soumya Dey, Angan Karmakar, Sonali Dey

Zitieren

APA

Bhowmick, K., Roongta, R., Mondal, S., Ghosh, D. N., Dey, S., Panjabi, G. R., Karmakar, A., Kumar, M. S., Dey, S., Ghorai, S., Ghorai, P., Sit, H., Haldar, S., Sinhamahapatra, P., Ghosh, B., Sircar, G., & Ghosh, P. (2025). Clinical profile and risk factors of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: A case-control study. Lupus. https://doi.org/10.1177/09612033251366401

Vancouver

Bhowmick K, Roongta R, Mondal S, Ghosh DN, Dey S, Panjabi GR, et al. Clinical profile and risk factors of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: A case-control study. Lupus. 2025. doi:10.1177/09612033251366401

BibTeX
@article{Bhowmick2025,
  author = {Bhowmick, Kaustav and Roongta, Rashmi and Mondal, Sumantro and Ghosh, Dipendra Nath and Dey, Soumya and Panjabi, Gautam Raj and Karmakar, Angan and Kumar, Mavidi Sunil and Dey, Sonali and Ghorai, Sudipta and Ghorai, Partha and Sit, Hiramanik and Haldar, Subhankar and Sinhamahapatra, Pradyot and Ghosh, Biswadip and Sircar, Geetabali and Ghosh, Parasar},
  title = {Clinical profile and risk factors of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: A case-control study},
  journal = {Lupus},
  year = {2025},
  doi = {10.1177/09612033251366401}
}
Kostenlos starten →